Evidence map›Paper›PMID 41612126›Full record

ArticleJournal of cardiovascular electrophysiology2026

Long-Term Follow-Up of Radiofrequency Slow Pathway Ablation for Atrioventricular Nodal Re-Entrant Tachycardia: Late Outcomes.

Emma Yaakop, Stephen Browitt, Catherine Cruickshank, Judy Greenslade, Iain Melton, Matthew Daly, Geoffrey Clare, Ross Downey, Daniel Garofalo, Ian Crozier

Abstract read
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emma YaakopDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Stephen BrowittDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Catherine CruickshankDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Judy GreensladeDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Iain MeltonDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Matthew DalyDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Geoffrey ClareDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Ross DowneyDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Daniel GarofaloDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.
Ian CrozierDepartment of Cardiology, Christchurch Hospital, Christchurch, New Zealand.ORCID 0000-0003-4652-7791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSlow pathway radiofrequency ablation is an effective treatment for atrioventricular nodal re-entrant tachycardia (AVNRT) but has been reported in some series to result in late atrioventricular block. We examined our local experience with a retrospective review.

methodsA retrospective review of all patients undergoing slow pathway ablation at our institution from 1993 through to 2021 was undertaken, with long-term outcomes reported till the end of 2022. Outcomes assessed included late atrioventricular block, and rhythm control.

resultsWe identified a total of 1290 procedures performed on 1256 patients over the 28-year period. Mean patient age at the time of the procedure was 48.5 years (range 13 to 93 years). A total of 1234 patients were followed up, whilst 22 were lost to follow-up. Mean follow up was 12.6 years (range 1 to 29 years). Of this cohort 9 patients subsequently developed atrioventricular block and proceeded to pacemaker implantation, for an incidence of 0.58 per 1000 patient years. Overall long-term rhythm controlled was achieved in 1221 (97%) patients.

conclusionsWe report what we believe to be the largest single centre experience, with the longest follow-up for slow pathway ablation, for AVNRT. We observed a low rate of late atrioventricular block that was not clearly higher than the spontaneous rate of heart block, yet still achieving good rhythm control. We believe our data supports radiofrequency slow pathway modification as effective and safe therapy for atrioventricular nodal re-entrant tachycardia.

Indexed as

Catheter AblationHeart RateTachycardia, Atrioventricular Nodal ReentryAction PotentialsAdolescentAdultAgedAged, 80 and overAtrioventricular BlockFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsTime Factors

Identifiers

PMID41612126
PMCPMC13069915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.